| Literature DB >> 34012162 |
M Ortega-Peña1, R González-Cuevas2.
Abstract
Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.Keywords: Antimalarials; Chloroquine; Coronavirus; Hydroxychloroquine; Ivermectin; Melatonin; Severe acute respiratory syndrome
Mesh：
Substances：
Year: 2020 PMID： 34012162 PMCID： PMC7756155 DOI： 10.1016/j.adengl.2020.09.015
Source DB: PubMed Journal: Actas Dermosifiliogr ISSN： 0001-7310